SEI Investments’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
Other funds holding TERN
ACA
VCM
HI
SEI Investments's TERN Position: Q1 2026 in Review
SEI Investments increased its Terns Pharmaceuticals (TERN) stake by 19% in Q1 2026, buying an estimated $367K and bringing the position to 56,061 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1822.
SEI Investments first reported a position in TERN in Q4 2025 and has held it in 2 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.
- SEI Investments held 56,061 shares of Terns Pharmaceuticals worth $2.96M as of Q1 2026.
- SEI Investments bought 8,946 Terns Pharmaceuticals shares in Q1 2026, an estimated $367K.
- Terns Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #1822 holding.
- SEI Investments first reported a position in Terns Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.